Celltrion, Institutional Investors Net Sell 223,948 Shares Over Last 5 Days... Stock Price 287,500 KRW (0.0%)

As of 2:33 PM on the 19th, Celltrion is trading at 287,500 KRW, unchanged from the previous day. The trading volume is 851,422 shares, which is 110.39% of the previous day's volume. Celltrion is known as a protein and biopharmaceutical manufacturing company.

On June 17, researcher Lee Dal-mi of SK Securities stated, "Acquired Takeda Primary Care Asia-Pacific division. Obtained all rights to 12 original prescription drug brands and 6 over-the-counter drug brands. This acquisition is expected to propel the company into a global comprehensive pharmaceutical company. The favorable performance growth continuing through the second half, short-selling ban, and development of COVID-19 treatments are expected to act as positive momentum for stock price increases in the second half." Lee set Celltrion's target price at 370,000 KRW.

Over the past five days, individual investors have net purchased 196,406 shares of Celltrion, while foreigners and institutions have net purchased 44,709 shares and net sold 223,948 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.